Mar Vista Investment Partners LLC lessened its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 5.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 107,065 shares of the conglomerate’s stock after selling 6,532 shares during the quarter. Danaher accounts for about 2.2% of Mar Vista Investment Partners LLC’s holdings, making the stock its 20th biggest position. Mar Vista Investment Partners LLC’s holdings in Danaher were worth $24,509,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. Elevated Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter valued at about $26,000. Hilton Head Capital Partners LLC bought a new position in Danaher in the 4th quarter worth $27,000. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 53 shares during the period. JPL Wealth Management LLC bought a new stake in shares of Danaher in the third quarter valued at approximately $25,000. Finally, WFA of San Diego LLC bought a new stake in shares of Danaher in the second quarter valued at approximately $26,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Wall Street Analyst Weigh In
DHR has been the subject of several research reports. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. The Goldman Sachs Group dropped their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Morgan Stanley decreased their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Finally, Royal Bank Of Canada assumed coverage on shares of Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $233.61.
Danaher Price Performance
NYSE DHR opened at $181.57 on Wednesday. The business has a 50 day simple moving average of $180.54 and a 200 day simple moving average of $203.94. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a market cap of $128.51 billion, a price-to-earnings ratio of 35.12, a PEG ratio of 2.31 and a beta of 0.81.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the business earned $1.88 EPS. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s payout ratio is presently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
